A Markov model of the natural history of prostate cancer.

[1]  M. Soloway,et al.  Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group. , 1990, The Journal of urology.

[2]  W. Shipley,et al.  Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. , 1980, The Journal of urology.

[3]  Re: Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. , 1989, The Journal of urology.

[4]  R. Haapiainen.  Latent (pTO) prostatic carcinoma--a retrospective study of frequency and natural history. , 1986, Annales chirurgiae et gynaecologiae.

[5]  C. Percy,et al.  Cancer incidence and mortality in the United States, 1973-77. , 1981, National Cancer Institute monograph.

[6]  C. Mettlin,et al.  Epidemiologic observations from the American College of Surgeons' survey on prostate cancer , 1983, The Prostate.

[7]  H. Hedelin,et al.  The inhibitory effect of human urine on urease-induced crystallization in vitro. , 1986, The Journal of urology.

[8]  P. Walsh,et al.  Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. , 1986, The Journal of urology.

[9]  L. Holmberg,et al.  High 10-year survival rate in patients with early, untreated prostatic cancer. , 1992, JAMA.

[10]  P. Macaskill,et al.  Age and survival in prostatic carcinoma. , 1983, British journal of urology.

[11]  M. Hafermann,et al.  Adjuvant radiotherapy following radical prostatectomy: results and complications. , 1986, The Journal of urology.

[12]  R. Middleton,et al.  Selection of patients with stage B prostate cancer for radical prostatectomy. , 1990, The Urologic clinics of North America.

[13]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  I. Thompson,et al.  Expectant management of localized prostatic cancer , 1991, Cancer.

[15]  P. Schellhammer.  Radical prostatectomy. Patterns of local failure and survival in 67 patients. , 1988, Urology.

[16]  J. Moul,et al.  Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. , 1990, The Journal of urology.

[17]  Stephen G. Pauker,et al.  Prostatic Cancer in a Patient with Asymptomatic HIV Infection , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  I. Kemp,et al.  Cancer of the prostate. Do younger men have a poorer survival rate? , 1984, British journal of urology.

[19]  I. Thompson,et al.  Extended follow-up of stage A1 carcinoma of prostate. , 1989, Urology.

[20]  G. Harrison.  The prognosis of prostatic cancer in the younger man. , 1983, British journal of urology.

[21]  M. Blute,et al.  Long-term followup of young patients with stage A adenocarcinoma of the prostate. , 1986, The Journal of urology.

[22]  Localized prostatic cancer. , 1987, IMJ. Illinois medical journal.

[23]  H. Adami,et al.  NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.

[24]  P. Walsh,et al.  Radical prostatectomy for the treatment of localized prostatic carcinoma. , 1980, The Urologic clinics of North America.

[25]  A. deMoura,et al.  [Cancer of the prostate]. , 1962, Jornal do medico.

[26]  L. Potters,et al.  Diminished Survival of Young Blacks With Adenocarcinoma of the Prostate , 1990, American journal of clinical oncology.

[27]  W. A. Gardner,et al.  Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. , 1982, The Journal of urology.

[28]  D. Byar.  The veterans administration cooperative urological research group's studies of cancer of the prostate , 1973, Cancer.

[29]  M. Weinstein,et al.  Clinical Decision Analysis , 1980 .

[30]  A. Rademaker,et al.  Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.

[31]  N. George.  NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONE , 1988, The Lancet.

[32]  E. Kramolowsky.  The value of testosterone deprivation in stage D1 carcinoma of the prostate. , 1988, The Journal of urology.

[33]  T. Tong,et al.  Cancer statistics, 1991 , 1991, CA: a cancer journal for clinicians.

[34]  S G Pauker,et al.  Clinical decision analysis by personal computer. , 1981, Archives of internal medicine.

[35]  W. Catalona,et al.  Staging errors in clinically localized prostatic cancer. , 1982, The Journal of urology.

[36]  Edwin Silverberg,et al.  Statistical and epidemiologic data on urologic cancer , 1987, Cancer.

[37]  Potential for radiotherapy alone in prostatic cancer , 1985, Cancer.

[38]  G. A. King,et al.  External beam radiotherapy for carcinoma of the prostate , 1989, Cancer.

[39]  D. Assimos,et al.  Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate , 1983, The Prostate.

[40]  Re: Management of stage a prostate cancer with a high probability of progression. , 1989, The Journal of urology.

[41]  Edwin Silverberg,et al.  Probabilities of eventually developing and of dying of cancer: (Risk among persons previously undiagnosed with the cancer) , 1978, CA: a cancer journal for clinicians.

[42]  M. Listrom,et al.  Incidental carcinoma of the prostate: an analysis of the predictors of progression. , 1988, The Journal of urology.

[43]  M. Anscher,et al.  Postoperative Radiotherapy for Patients with Carcinoma of the Prostate Undergoing Radical Prostatectomy with Positive Surgical Margins, Seminal Vesicle Involvement and/or Penetration Through the Capsule , 1987 .

[44]  I M Thompson,et al.  Economics of screening for carcinoma of the prostate. , 1990, The Urologic clinics of North America.

[45]  Selection criteria for radical prostatectomy based on morphometric studies in prostate carcinoma. , 1988, NCI monographs : a publication of the National Cancer Institute.

[46]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.

[47]  J. Smith,et al.  Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastasis from adenocarcinoma of the prostate. , 1984, The Journal of urology.

[48]  Y. Reinberg,et al.  Long-term followup results after expectant management of stage A1 prostatic cancer. , 1991, The Journal of urology.

[49]  J. Smith,et al.  Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. , 1986, The Journal of urology.

[50]  The Prognosis of Prostatic Cancer in the Younger Man , 1984 .

[51]  Background for screening: natural history and treatment. , 1988, Progress in clinical and biological research.

[52]  T. Fleming,et al.  Course of localized adenocarcinoma of the prostate treated by radical prostatectomy , 1983, The Prostate.

[53]  P. Scardino,et al.  Prognostic significance of lymph nodal metastases in prostate cancer. , 1989, The Journal of urology.

[54]  F. K. Arnheim.  Carcinoma of the Prostate: A Study of the Postmortem Findings in One Hundred and Seventy-Six Cases , 1948 .

[55]  T. Therneau,et al.  Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. , 1989, The Journal of urology.

[56]  R. Beart,et al.  Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. , 1986, The Journal of urology.

[57]  H. Dayal,et al.  Factors associated with racial differences in survival for prostatic carcinoma. , 1982, Journal of chronic diseases.

[58]  R. Gibbons,et al.  Total prostatectomy for clinically localized prostatic cancer: long-term results. , 1989, The Journal of urology.

[59]  Hanks Ge.  External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States. , 1988 .

[60]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[61]  R. Gittes.  Carcinoma of the prostate. , 1991, The New England journal of medicine.

[62]  P. Brawn,et al.  Stage D1 prostate carcinoma the histologic appearance of nodal metastases and its relationship to survival , 1990, Cancer.

[63]  J. Mulcahy,et al.  Carcinoma of the prostate. , 1978, The Journal of the Kentucky Medical Association.

[64]  G. Murphy,et al.  Prostatic carcinoma treated at categorical center: clinical and pathologic observations. , 1972, New York state journal of medicine.

[65]  H. Zincke.  Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome. , 1989, Urology.

[66]  S. Piantadosi,et al.  Clinical evidence for and implications of the multistep development of prostate cancer. , 1990, The Journal of urology.

[67]  Mortality in prostatic carcinoma. , 1986, Urology.

[68]  J. McNeal,et al.  Origin and development of carcinoma in the prostate , 1969, Cancer.

[69]  Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer , 1989 .

[70]  Survival and mortality in prostatic cancer. A study based on the Swedish Cancer Register. , 1991, Acta oncologica.

[71]  Montie Je.  Significance and treatment of positive margins or seminal vesicle invasion after radical prostatectomy. , 1990 .

[72]  M. Boileau,et al.  Interstitial gold and external beam irradiation for prostate cancer. , 1988, The Journal of urology.

[73]  I. Bross,et al.  The metastatic spread of kidney and prostate cancers in man. , 1976, Neoplasma.

[74]  P. H. Powell,et al.  Deferred treatment for prostate cancer. , 1988, British journal of urology.

[75]  T. Stamey,et al.  Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. , 1988, The Journal of urology.

[76]  J. Johansson,et al.  Deferred treatment in localized prostatic cancer. , 1991, Acta oncologica.

[77]  Prostatic oncology. , 1990, Clinics in geriatric medicine.

[78]  W. Whitmore,et al.  Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. , 1977, The Journal of urology.

[79]  M. Mason,et al.  Cancer of the prostate , 2003 .

[80]  W. Whitmore.  Natural history of low-stage prostatic cancer and the impact of early detection. , 1990, The Urologic clinics of North America.

[81]  W. Boyce,et al.  Radical prostatectomy: palliation for stage C carcinoma of the prostate. , 1977, The Journal of urology.

[82]  P. Scardino,et al.  Early detection of prostate cancer. , 1989, The Urologic clinics of North America.

[83]  G. Murphy,et al.  Prostatic carcinoma. Treated at categorical center, 1960-1969. , 1975, New York state journal of medicine.

[84]  J R Beck,et al.  A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. , 1982, The American journal of medicine.

[85]  J. Adolfsson,et al.  Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. , 1991, The Journal of urology.

[86]  D. Kuban,et al.  Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma , 1989, Cancer.

[87]  L. Kavoussi,et al.  Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. , 1988, The Journal of urology.

[88]  G. Murphy,et al.  Lymph node involvement in prostatic carcinoma. , 1975, The Urologic clinics of North America.

[89]  D. Paulson,et al.  Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate. , 1984, The Journal of urology.

[90]  P. Walsh,et al.  Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. , 1981, The Journal of urology.

[91]  Z. Petrovich,et al.  Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy. , 1989, The Journal of urology.

[92]  Leuprolide versus diethylstilbestrol for metastatic prostate cancer. , 1984, The New England journal of medicine.

[93]  J. Shimazaki.  [Prostatic cancer]. , 1989, Gan no rinsho. Japan journal of cancer clinics.

[94]  M. Listrom,et al.  Management of stage A prostate cancer with a high probability of progression. , 1988, The Journal of urology.